| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 59 | 2023 | 859 | 6.280 |
Why?
|
| Heart Failure | 33 | 2023 | 2299 | 2.380 |
Why?
|
| Cardiomyopathies | 17 | 2023 | 500 | 2.190 |
Why?
|
| Heart-Assist Devices | 22 | 2022 | 1027 | 1.630 |
Why?
|
| Cardiomyopathy, Restrictive | 7 | 2020 | 21 | 1.610 |
Why?
|
| Graft Rejection | 23 | 2023 | 588 | 1.470 |
Why?
|
| Cardiomyopathy, Hypertrophic | 7 | 2019 | 157 | 1.290 |
Why?
|
| Cardiomyopathy, Dilated | 10 | 2023 | 216 | 1.250 |
Why?
|
| Death, Sudden, Cardiac | 8 | 2020 | 259 | 1.160 |
Why?
|
| Child | 104 | 2024 | 24617 | 1.150 |
Why?
|
| Myocarditis | 8 | 2019 | 130 | 0.980 |
Why?
|
| Child, Preschool | 75 | 2024 | 14151 | 0.890 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 5 | 2023 | 44 | 0.880 |
Why?
|
| Ventricular Function, Left | 9 | 2022 | 514 | 0.850 |
Why?
|
| Donor Selection | 2 | 2020 | 54 | 0.810 |
Why?
|
| Heart Valve Diseases | 3 | 2021 | 174 | 0.790 |
Why?
|
| Waiting Lists | 4 | 2020 | 227 | 0.790 |
Why?
|
| Adolescent | 68 | 2021 | 19430 | 0.780 |
Why?
|
| Retrospective Studies | 60 | 2024 | 16369 | 0.780 |
Why?
|
| Immunosuppressive Agents | 8 | 2022 | 645 | 0.740 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 79 | 0.720 |
Why?
|
| Heart Ventricles | 7 | 2022 | 783 | 0.690 |
Why?
|
| Infant | 63 | 2024 | 12604 | 0.680 |
Why?
|
| Humans | 131 | 2024 | 125362 | 0.660 |
Why?
|
| Organ Transplantation | 1 | 2022 | 168 | 0.640 |
Why?
|
| Echocardiography, Doppler | 5 | 2015 | 171 | 0.610 |
Why?
|
| Pericarditis | 1 | 2019 | 42 | 0.600 |
Why?
|
| Echocardiography | 9 | 2024 | 1067 | 0.570 |
Why?
|
| Male | 87 | 2024 | 61566 | 0.570 |
Why?
|
| Coronary Artery Disease | 5 | 2012 | 805 | 0.570 |
Why?
|
| Ventricular Dysfunction, Left | 9 | 2017 | 374 | 0.550 |
Why?
|
| Female | 92 | 2024 | 66821 | 0.550 |
Why?
|
| Natriuretic Peptide, Brain | 8 | 2019 | 313 | 0.540 |
Why?
|
| Cardiac Catheterization | 9 | 2023 | 633 | 0.530 |
Why?
|
| Ventricular Pressure | 2 | 2015 | 41 | 0.520 |
Why?
|
| Heart Defects, Congenital | 12 | 2018 | 1832 | 0.520 |
Why?
|
| Cyclosporine | 2 | 2014 | 145 | 0.480 |
Why?
|
| Postoperative Complications | 17 | 2022 | 3056 | 0.470 |
Why?
|
| Arrhythmias, Cardiac | 7 | 2022 | 459 | 0.470 |
Why?
|
| Muscle Cells | 1 | 2014 | 24 | 0.460 |
Why?
|
| Graft Survival | 8 | 2021 | 532 | 0.460 |
Why?
|
| Tacrolimus | 1 | 2014 | 97 | 0.450 |
Why?
|
| Electrocardiography | 11 | 2019 | 978 | 0.450 |
Why?
|
| Gestational Age | 1 | 2017 | 1169 | 0.420 |
Why?
|
| Infant, Newborn | 30 | 2023 | 8273 | 0.420 |
Why?
|
| Anemia, Iron-Deficiency | 3 | 2021 | 138 | 0.420 |
Why?
|
| Coronary Stenosis | 2 | 2005 | 77 | 0.420 |
Why?
|
| Prosthesis Implantation | 3 | 2020 | 140 | 0.410 |
Why?
|
| Body Mass Index | 3 | 2021 | 1563 | 0.410 |
Why?
|
| Treatment Outcome | 35 | 2022 | 12287 | 0.400 |
Why?
|
| Liver Transplantation | 1 | 2021 | 1042 | 0.400 |
Why?
|
| Extracorporeal Membrane Oxygenation | 5 | 2024 | 617 | 0.380 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2011 | 29 | 0.370 |
Why?
|
| Cohort Studies | 15 | 2021 | 4828 | 0.370 |
Why?
|
| Ventricular Function, Right | 2 | 2022 | 113 | 0.330 |
Why?
|
| Heart Failure, Systolic | 2 | 2021 | 34 | 0.330 |
Why?
|
| Parvoviridae Infections | 4 | 2013 | 36 | 0.320 |
Why?
|
| Stroke Volume | 9 | 2017 | 496 | 0.320 |
Why?
|
| Oxidative Stress | 1 | 2014 | 818 | 0.320 |
Why?
|
| Tachycardia, Ventricular | 5 | 2016 | 192 | 0.310 |
Why?
|
| Myocardium | 9 | 2023 | 1022 | 0.310 |
Why?
|
| Tissue Donors | 4 | 2021 | 483 | 0.300 |
Why?
|
| Kaplan-Meier Estimate | 10 | 2021 | 1065 | 0.300 |
Why?
|
| Survival Rate | 9 | 2021 | 2050 | 0.290 |
Why?
|
| Heart Diseases | 3 | 2010 | 496 | 0.280 |
Why?
|
| Predictive Value of Tests | 11 | 2017 | 2182 | 0.270 |
Why?
|
| Registries | 5 | 2021 | 1434 | 0.270 |
Why?
|
| Cachexia | 1 | 2007 | 48 | 0.270 |
Why?
|
| Follow-Up Studies | 20 | 2019 | 5171 | 0.270 |
Why?
|
| Young Adult | 11 | 2023 | 9061 | 0.270 |
Why?
|
| Multivariate Analysis | 7 | 2019 | 1427 | 0.270 |
Why?
|
| Hospitals, Pediatric | 6 | 2018 | 766 | 0.260 |
Why?
|
| Hospitalization | 8 | 2022 | 1791 | 0.260 |
Why?
|
| Age Factors | 8 | 2020 | 2818 | 0.260 |
Why?
|
| Infusions, Parenteral | 1 | 2006 | 99 | 0.250 |
Why?
|
| Milrinone | 1 | 2006 | 29 | 0.250 |
Why?
|
| Vascular Resistance | 3 | 2016 | 189 | 0.250 |
Why?
|
| Parvovirus B19, Human | 4 | 2013 | 30 | 0.250 |
Why?
|
| Leukopenia | 1 | 2005 | 45 | 0.240 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2007 | 164 | 0.240 |
Why?
|
| Cardiotonic Agents | 2 | 2006 | 139 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2005 | 49 | 0.240 |
Why?
|
| Risk Factors | 21 | 2019 | 10298 | 0.240 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2004 | 1123 | 0.240 |
Why?
|
| Prognosis | 13 | 2019 | 4686 | 0.240 |
Why?
|
| Adult | 24 | 2023 | 29543 | 0.240 |
Why?
|
| Biopsy | 7 | 2023 | 1244 | 0.230 |
Why?
|
| Trisomy | 1 | 2005 | 102 | 0.230 |
Why?
|
| Leukocytes | 1 | 2005 | 212 | 0.230 |
Why?
|
| Body Weight | 1 | 2008 | 989 | 0.230 |
Why?
|
| Dopamine | 1 | 2006 | 282 | 0.220 |
Why?
|
| United States | 11 | 2022 | 10909 | 0.220 |
Why?
|
| Cannula | 1 | 2024 | 27 | 0.220 |
Why?
|
| Time Factors | 14 | 2020 | 6311 | 0.220 |
Why?
|
| Heart | 6 | 2022 | 731 | 0.220 |
Why?
|
| Respiratory Insufficiency | 2 | 2024 | 226 | 0.220 |
Why?
|
| Hospital Charges | 2 | 2015 | 60 | 0.210 |
Why?
|
| Exercise Test | 3 | 2016 | 254 | 0.210 |
Why?
|
| Diastole | 4 | 2020 | 178 | 0.210 |
Why?
|
| Mitral Valve | 2 | 2015 | 252 | 0.210 |
Why?
|
| DNA, Viral | 4 | 2013 | 478 | 0.210 |
Why?
|
| Ambulatory Care | 2 | 2006 | 391 | 0.210 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 2 | 2022 | 32 | 0.210 |
Why?
|
| Tissue and Organ Procurement | 2 | 2020 | 222 | 0.200 |
Why?
|
| Risk Assessment | 5 | 2020 | 3431 | 0.200 |
Why?
|
| Natriuretic Agents | 3 | 2007 | 33 | 0.200 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2016 | 111 | 0.200 |
Why?
|
| Hypertension, Pulmonary | 4 | 2016 | 439 | 0.190 |
Why?
|
| Cardiac Output, Low | 3 | 2007 | 67 | 0.190 |
Why?
|
| Pulmonary Artery | 3 | 2015 | 438 | 0.190 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2022 | 78 | 0.180 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2022 | 224 | 0.180 |
Why?
|
| Sarcomeres | 3 | 2022 | 31 | 0.180 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 465 | 0.180 |
Why?
|
| Connectin | 1 | 2020 | 27 | 0.180 |
Why?
|
| Hemodynamics | 4 | 2022 | 849 | 0.180 |
Why?
|
| Wolff-Parkinson-White Syndrome | 2 | 2019 | 72 | 0.170 |
Why?
|
| Kidney Transplantation | 2 | 2021 | 653 | 0.170 |
Why?
|
| Death, Sudden | 2 | 2010 | 45 | 0.170 |
Why?
|
| Shock, Cardiogenic | 2 | 2007 | 193 | 0.170 |
Why?
|
| Diuretics | 2 | 2022 | 171 | 0.160 |
Why?
|
| Myocardial Contraction | 2 | 2020 | 265 | 0.160 |
Why?
|
| Noonan Syndrome | 1 | 2019 | 30 | 0.160 |
Why?
|
| Endocardium | 3 | 2013 | 51 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 3176 | 0.160 |
Why?
|
| Coronary Angiography | 3 | 2016 | 449 | 0.150 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2019 | 97 | 0.150 |
Why?
|
| Patient Admission | 2 | 2013 | 185 | 0.150 |
Why?
|
| Hospital Mortality | 4 | 2020 | 1027 | 0.150 |
Why?
|
| Device Removal | 2 | 2018 | 218 | 0.150 |
Why?
|
| Overweight | 1 | 2021 | 363 | 0.150 |
Why?
|
| Defibrillators, Implantable | 2 | 2012 | 190 | 0.150 |
Why?
|
| Texas | 8 | 2018 | 3581 | 0.150 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 1902 | 0.150 |
Why?
|
| Aortic Valve | 1 | 2021 | 445 | 0.150 |
Why?
|
| Tracheostomy | 1 | 2020 | 196 | 0.150 |
Why?
|
| Aorta | 2 | 2017 | 545 | 0.150 |
Why?
|
| Obesity | 2 | 2021 | 2252 | 0.150 |
Why?
|
| Troponin T | 1 | 2020 | 284 | 0.140 |
Why?
|
| Amino Acids | 1 | 2020 | 668 | 0.140 |
Why?
|
| Incidence | 9 | 2017 | 3134 | 0.140 |
Why?
|
| Acute Disease | 2 | 2019 | 1097 | 0.140 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 294 | 0.140 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 2014 | 145 | 0.140 |
Why?
|
| Walking | 1 | 2019 | 216 | 0.140 |
Why?
|
| Surgical Fixation Devices | 1 | 2017 | 3 | 0.140 |
Why?
|
| Thrombosis | 1 | 2022 | 524 | 0.140 |
Why?
|
| Pectus Carinatum | 1 | 2017 | 5 | 0.140 |
Why?
|
| Disease Progression | 5 | 2016 | 2084 | 0.140 |
Why?
|
| Titanium | 1 | 2017 | 20 | 0.140 |
Why?
|
| Wound Closure Techniques | 1 | 2017 | 23 | 0.130 |
Why?
|
| Anthracyclines | 1 | 2017 | 37 | 0.130 |
Why?
|
| Myocardial Ischemia | 2 | 2016 | 345 | 0.130 |
Why?
|
| Coronary Disease | 4 | 2010 | 675 | 0.130 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2017 | 52 | 0.130 |
Why?
|
| Consensus | 1 | 2020 | 644 | 0.130 |
Why?
|
| Ultrasonography | 3 | 2012 | 939 | 0.130 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2017 | 40 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2016 | 32 | 0.130 |
Why?
|
| Clostridium Infections | 1 | 2019 | 245 | 0.130 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2017 | 128 | 0.130 |
Why?
|
| Gadolinium DTPA | 1 | 2016 | 47 | 0.130 |
Why?
|
| Hypertrophy | 1 | 2016 | 104 | 0.120 |
Why?
|
| Hyponatremia | 1 | 2016 | 72 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 2061 | 0.120 |
Why?
|
| Proportional Hazards Models | 6 | 2019 | 1362 | 0.120 |
Why?
|
| Global Health | 1 | 2020 | 570 | 0.120 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1997 | 223 | 0.120 |
Why?
|
| Heart Septum | 1 | 2015 | 54 | 0.120 |
Why?
|
| Tachycardia | 4 | 2013 | 70 | 0.120 |
Why?
|
| Ventricular Dysfunction | 1 | 2015 | 25 | 0.120 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2016 | 160 | 0.120 |
Why?
|
| Mortality | 1 | 2016 | 238 | 0.120 |
Why?
|
| Prosthesis Design | 4 | 2020 | 668 | 0.120 |
Why?
|
| Comorbidity | 4 | 2019 | 1528 | 0.120 |
Why?
|
| Anemia | 1 | 2018 | 341 | 0.120 |
Why?
|
| Heart Arrest | 2 | 2017 | 356 | 0.110 |
Why?
|
| Prosthesis Failure | 1 | 2015 | 156 | 0.110 |
Why?
|
| Arterial Pressure | 1 | 2015 | 112 | 0.110 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 2880 | 0.110 |
Why?
|
| Ebstein Anomaly | 1 | 2014 | 27 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 1 | 2021 | 887 | 0.110 |
Why?
|
| Recovery of Function | 4 | 2020 | 433 | 0.110 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2014 | 73 | 0.110 |
Why?
|
| Algorithms | 2 | 2011 | 1633 | 0.110 |
Why?
|
| Fontan Procedure | 1 | 2016 | 184 | 0.100 |
Why?
|
| Down Syndrome | 1 | 2016 | 198 | 0.100 |
Why?
|
| Immunologic Factors | 1 | 2014 | 173 | 0.100 |
Why?
|
| Pregnancy Outcome | 1 | 2016 | 596 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 1714 | 0.100 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2016 | 257 | 0.100 |
Why?
|
| Virus Diseases | 2 | 2011 | 281 | 0.100 |
Why?
|
| Health Care Costs | 1 | 2015 | 372 | 0.100 |
Why?
|
| Blindness | 1 | 1993 | 72 | 0.100 |
Why?
|
| Transposition of Great Vessels | 2 | 2004 | 132 | 0.100 |
Why?
|
| Anticoagulants | 2 | 2022 | 578 | 0.100 |
Why?
|
| Cicatrix | 1 | 1993 | 124 | 0.100 |
Why?
|
| Pseudomonas Infections | 1 | 2013 | 114 | 0.100 |
Why?
|
| Pseudotumor Cerebri | 1 | 1993 | 58 | 0.090 |
Why?
|
| Candidiasis | 1 | 2013 | 129 | 0.090 |
Why?
|
| Cause of Death | 2 | 2007 | 473 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2016 | 1189 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2023 | 4595 | 0.090 |
Why?
|
| Genome, Viral | 2 | 2010 | 166 | 0.090 |
Why?
|
| Databases, Factual | 4 | 2017 | 1172 | 0.090 |
Why?
|
| Endomyocardial Fibrosis | 1 | 2010 | 3 | 0.090 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2015 | 437 | 0.090 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2010 | 21 | 0.090 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2016 | 972 | 0.090 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2013 | 293 | 0.080 |
Why?
|
| Genotype | 3 | 2016 | 2570 | 0.080 |
Why?
|
| Histocompatibility Testing | 1 | 2010 | 144 | 0.080 |
Why?
|
| Intensive Care Units | 1 | 2013 | 494 | 0.080 |
Why?
|
| Survival Analysis | 3 | 2009 | 1495 | 0.080 |
Why?
|
| Drug Therapy, Combination | 3 | 2010 | 1172 | 0.080 |
Why?
|
| Renal Insufficiency | 2 | 2015 | 239 | 0.080 |
Why?
|
| Chyle | 1 | 1989 | 4 | 0.080 |
Why?
|
| HLA Antigens | 1 | 2010 | 238 | 0.080 |
Why?
|
| Pericardial Effusion | 1 | 1989 | 63 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2010 | 242 | 0.080 |
Why?
|
| Pacemaker, Artificial | 2 | 2017 | 174 | 0.080 |
Why?
|
| Antibodies | 1 | 2010 | 374 | 0.080 |
Why?
|
| Systole | 3 | 2022 | 201 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 1694 | 0.080 |
Why?
|
| Survival | 1 | 2008 | 19 | 0.080 |
Why?
|
| Catheter Ablation | 2 | 2005 | 233 | 0.070 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 562 | 0.070 |
Why?
|
| Transplant Recipients | 2 | 2020 | 220 | 0.070 |
Why?
|
| Prospective Studies | 7 | 2018 | 6141 | 0.070 |
Why?
|
| Glomerular Filtration Rate | 2 | 2021 | 510 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2023 | 2373 | 0.070 |
Why?
|
| Hypotension | 1 | 2009 | 186 | 0.070 |
Why?
|
| Reoperation | 2 | 2008 | 830 | 0.070 |
Why?
|
| Length of Stay | 3 | 2019 | 1310 | 0.070 |
Why?
|
| Transplantation Immunology | 1 | 2007 | 53 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1692 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 4 | 2012 | 1592 | 0.070 |
Why?
|
| Nutritional Status | 1 | 2008 | 316 | 0.060 |
Why?
|
| Syndrome | 2 | 2008 | 1121 | 0.060 |
Why?
|
| Glycogen Storage Disease Type IIb | 1 | 2005 | 6 | 0.060 |
Why?
|
| Severity of Illness Index | 5 | 2016 | 2909 | 0.060 |
Why?
|
| Tertiary Care Centers | 2 | 2019 | 237 | 0.060 |
Why?
|
| Codon, Nonsense | 1 | 2005 | 131 | 0.060 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2017 | 248 | 0.060 |
Why?
|
| Cytomegalovirus Infections | 2 | 1997 | 223 | 0.060 |
Why?
|
| Arginine Vasopressin | 1 | 2004 | 29 | 0.060 |
Why?
|
| Probability | 2 | 2019 | 318 | 0.050 |
Why?
|
| Kidney Diseases | 1 | 2008 | 485 | 0.050 |
Why?
|
| Exercise | 1 | 2009 | 814 | 0.050 |
Why?
|
| Prevalence | 3 | 2018 | 2467 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 1 | 2023 | 122 | 0.050 |
Why?
|
| Mutation | 3 | 2019 | 5905 | 0.050 |
Why?
|
| Abdominal Pain | 1 | 2005 | 306 | 0.050 |
Why?
|
| Dilatation, Pathologic | 1 | 2003 | 94 | 0.050 |
Why?
|
| Resuscitation | 1 | 2005 | 252 | 0.050 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2004 | 147 | 0.050 |
Why?
|
| Animals | 4 | 2023 | 34319 | 0.050 |
Why?
|
| Chlorides | 1 | 2022 | 107 | 0.050 |
Why?
|
| Phenotype | 2 | 2010 | 4270 | 0.050 |
Why?
|
| Case-Control Studies | 4 | 2019 | 3313 | 0.050 |
Why?
|
| Atrial Flutter | 2 | 2013 | 33 | 0.050 |
Why?
|
| Hirudins | 1 | 2022 | 37 | 0.050 |
Why?
|
| Aortography | 1 | 2003 | 190 | 0.050 |
Why?
|
| Neoplasms | 1 | 1997 | 2799 | 0.050 |
Why?
|
| Actin Cytoskeleton | 1 | 2022 | 44 | 0.050 |
Why?
|
| Antithrombins | 1 | 2022 | 56 | 0.050 |
Why?
|
| Transferrin | 1 | 2021 | 49 | 0.050 |
Why?
|
| Critical Care | 1 | 2007 | 656 | 0.050 |
Why?
|
| Thinness | 1 | 2021 | 71 | 0.050 |
Why?
|
| Sodium | 1 | 2022 | 299 | 0.050 |
Why?
|
| Hemolysis | 1 | 2021 | 111 | 0.050 |
Why?
|
| Coronary Vessels | 1 | 2005 | 531 | 0.050 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 2016 | 61 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 3605 | 0.040 |
Why?
|
| Heparin | 1 | 2022 | 216 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2020 | 41 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2022 | 274 | 0.040 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2015 | 112 | 0.040 |
Why?
|
| ROC Curve | 2 | 2016 | 572 | 0.040 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2020 | 50 | 0.040 |
Why?
|
| Recurrence | 2 | 2019 | 1394 | 0.040 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2000 | 76 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 22 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2019 | 19 | 0.040 |
Why?
|
| Genes, ras | 1 | 2019 | 100 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2022 | 414 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2020 | 186 | 0.040 |
Why?
|
| Bilirubin | 1 | 2019 | 125 | 0.040 |
Why?
|
| Iron | 1 | 2021 | 277 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2022 | 467 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2023 | 641 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2022 | 1400 | 0.040 |
Why?
|
| Unnecessary Procedures | 1 | 2019 | 60 | 0.040 |
Why?
|
| Azathioprine | 1 | 1998 | 54 | 0.040 |
Why?
|
| ras Proteins | 1 | 2019 | 139 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2006 | 1069 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2020 | 355 | 0.040 |
Why?
|
| Biomarkers | 4 | 2009 | 3106 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2022 | 781 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2019 | 335 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2020 | 475 | 0.040 |
Why?
|
| Aorta, Thoracic | 1 | 2003 | 526 | 0.040 |
Why?
|
| Exons | 1 | 2020 | 802 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2023 | 3044 | 0.040 |
Why?
|
| Prednisone | 1 | 1998 | 278 | 0.040 |
Why?
|
| Infusions, Intravenous | 3 | 2006 | 554 | 0.030 |
Why?
|
| Heart Atria | 1 | 2020 | 321 | 0.030 |
Why?
|
| Long QT Syndrome | 1 | 1998 | 83 | 0.030 |
Why?
|
| Potassium Channels | 1 | 1998 | 161 | 0.030 |
Why?
|
| Apoptosis | 1 | 2023 | 1818 | 0.030 |
Why?
|
| Cardiotoxicity | 1 | 2017 | 35 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1104 | 0.030 |
Why?
|
| Ganciclovir | 1 | 1997 | 105 | 0.030 |
Why?
|
| Logistic Models | 1 | 2021 | 1802 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 473 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2019 | 485 | 0.030 |
Why?
|
| Allografts | 1 | 2017 | 176 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2017 | 243 | 0.030 |
Why?
|
| Postoperative Care | 1 | 1998 | 301 | 0.030 |
Why?
|
| Oxygen | 1 | 2019 | 556 | 0.030 |
Why?
|
| Stroke | 2 | 2015 | 983 | 0.030 |
Why?
|
| Mice | 2 | 2023 | 17750 | 0.030 |
Why?
|
| Heart Septal Defects | 1 | 2016 | 38 | 0.030 |
Why?
|
| Opportunistic Infections | 1 | 1996 | 79 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 198 | 0.030 |
Why?
|
| Fetal Heart | 1 | 2016 | 120 | 0.030 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1997 | 143 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2003 | 1043 | 0.030 |
Why?
|
| Creatinine | 2 | 2007 | 394 | 0.030 |
Why?
|
| Endocardial Fibroelastosis | 1 | 1995 | 11 | 0.030 |
Why?
|
| Palliative Care | 2 | 2016 | 433 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2021 | 862 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 202 | 0.030 |
Why?
|
| Enterovirus | 2 | 2010 | 52 | 0.030 |
Why?
|
| Heart Rate | 2 | 2007 | 592 | 0.030 |
Why?
|
| Airway Obstruction | 1 | 2016 | 165 | 0.030 |
Why?
|
| Ductus Arteriosus | 1 | 1994 | 62 | 0.030 |
Why?
|
| Tachycardia, Ectopic Atrial | 1 | 1993 | 6 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 1961 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 2 | 2013 | 674 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 683 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2014 | 256 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2003 | 2603 | 0.030 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2004 | 282 | 0.030 |
Why?
|
| Pseudomonas | 1 | 2013 | 12 | 0.030 |
Why?
|
| Blood Flow Velocity | 2 | 2005 | 454 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 511 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 1086 | 0.030 |
Why?
|
| Amiodarone | 1 | 1993 | 45 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 1253 | 0.030 |
Why?
|
| Staphylococcus | 1 | 2013 | 69 | 0.030 |
Why?
|
| Arkansas | 1 | 2012 | 58 | 0.020 |
Why?
|
| Candida | 1 | 2013 | 75 | 0.020 |
Why?
|
| Dogs | 1 | 1993 | 773 | 0.020 |
Why?
|
| Contrast Media | 1 | 2016 | 480 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2019 | 725 | 0.020 |
Why?
|
| Morbidity | 1 | 2012 | 248 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 1997 | 768 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2008 | 2057 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2013 | 778 | 0.020 |
Why?
|
| Heart Conduction System | 1 | 1991 | 148 | 0.020 |
Why?
|
| Coxsackievirus Infections | 1 | 2010 | 10 | 0.020 |
Why?
|
| Preventive Medicine | 1 | 1990 | 21 | 0.020 |
Why?
|
| Adenoviridae Infections | 1 | 2010 | 71 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1993 | 1018 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2013 | 543 | 0.020 |
Why?
|
| Punctures | 1 | 1989 | 55 | 0.020 |
Why?
|
| Medical Records | 1 | 2009 | 191 | 0.020 |
Why?
|
| Isoantibodies | 1 | 2008 | 72 | 0.020 |
Why?
|
| Aortic Rupture | 1 | 1990 | 119 | 0.020 |
Why?
|
| Stents | 1 | 1994 | 835 | 0.020 |
Why?
|
| Immunoassay | 1 | 2008 | 131 | 0.020 |
Why?
|
| Tetralogy of Fallot | 1 | 1990 | 164 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 280 | 0.020 |
Why?
|
| Assisted Circulation | 1 | 2007 | 36 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2008 | 130 | 0.020 |
Why?
|
| Aldosterone | 1 | 2007 | 61 | 0.020 |
Why?
|
| Endothelin-1 | 1 | 2007 | 41 | 0.020 |
Why?
|
| Diuresis | 1 | 2007 | 58 | 0.020 |
Why?
|
| Renin | 1 | 2007 | 93 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 228 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2010 | 875 | 0.020 |
Why?
|
| Sepsis | 1 | 2012 | 484 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2010 | 605 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2007 | 176 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2656 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2007 | 257 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2008 | 430 | 0.020 |
Why?
|
| Blood Urea Nitrogen | 1 | 2006 | 76 | 0.020 |
Why?
|
| Electrolytes | 1 | 2006 | 53 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 433 | 0.020 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2005 | 10 | 0.020 |
Why?
|
| Papillary Muscles | 1 | 2005 | 20 | 0.020 |
Why?
|
| Inflammation | 1 | 2013 | 1445 | 0.020 |
Why?
|
| Aortic Valve Stenosis | 1 | 1990 | 338 | 0.020 |
Why?
|
| Drug Overdose | 1 | 2006 | 68 | 0.020 |
Why?
|
| Reference Values | 1 | 2006 | 719 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 461 | 0.010 |
Why?
|
| Muscular Diseases | 1 | 2005 | 103 | 0.010 |
Why?
|
| Outpatients | 1 | 2006 | 256 | 0.010 |
Why?
|
| Infant Welfare | 1 | 2004 | 28 | 0.010 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2004 | 22 | 0.010 |
Why?
|
| Observer Variation | 1 | 2005 | 300 | 0.010 |
Why?
|
| Medical Errors | 1 | 2006 | 154 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 2003 | 69 | 0.010 |
Why?
|
| Acyltransferases | 1 | 2003 | 44 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2004 | 165 | 0.010 |
Why?
|
| Mitochondrial Myopathies | 1 | 2003 | 28 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2005 | 729 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 7226 | 0.010 |
Why?
|
| Bradycardia | 1 | 2004 | 60 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 257 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 2004 | 121 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 241 | 0.010 |
Why?
|
| Exercise Tolerance | 1 | 2004 | 84 | 0.010 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2004 | 133 | 0.010 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2004 | 87 | 0.010 |
Why?
|
| Pulmonary Valve | 1 | 2004 | 92 | 0.010 |
Why?
|
| Chest Pain | 1 | 2004 | 129 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2004 | 305 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 2004 | 193 | 0.010 |
Why?
|
| Patient Selection | 1 | 2006 | 696 | 0.010 |
Why?
|
| Mass Screening | 1 | 2008 | 785 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2006 | 1377 | 0.010 |
Why?
|
| Kidney | 1 | 2007 | 1363 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2005 | 945 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1998 | 105 | 0.010 |
Why?
|
| Proteins | 1 | 2003 | 1039 | 0.010 |
Why?
|
| Parvovirus | 1 | 1996 | 8 | 0.010 |
Why?
|
| Adenoviruses, Human | 1 | 1996 | 81 | 0.010 |
Why?
|
| Simplexvirus | 1 | 1996 | 104 | 0.010 |
Why?
|
| Gene Deletion | 1 | 1998 | 793 | 0.010 |
Why?
|
| Cytomegalovirus | 1 | 1996 | 269 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1998 | 1320 | 0.010 |
Why?
|
| Child Development | 1 | 1995 | 269 | 0.010 |
Why?
|
| Vascular Surgical Procedures | 1 | 1997 | 554 | 0.010 |
Why?
|
| Telemetry | 1 | 1991 | 28 | 0.010 |
Why?
|
| Base Sequence | 1 | 1996 | 3111 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1996 | 3900 | 0.010 |
Why?
|